On Friday shares of Celgene Corporation (NASDAQ:CELG) closed at $118.71. Company’s sales growth for last 5 years was 23.30% and EPS growth for next 5 years is recorded as 25.46%. Celgene Corp.( NASDAQ:CELG) announced that it has fulfilled the accelerated approval requirements for Pomalyst (pomalidomide) based on results from MM-003, an international phase III study of POMALYST plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma patients.
Cytokinetics, Incorporated (NASDAQ:CYTK) in last trading activity decreased -2.42% to close at $7.25. Company weekly performance is 4.32% while its quarterly performance stands at -1.76%. Cytokinetics, Incorporated (NASDAQ:CYTK) is -45.32% away from its 52 week high. On Apr 17, Cytokinetics, Incorporated (NASDAQ:CYTK) announced that it is scheduled to report first quarter results on Thursday, April 30, 2015 at 4:00 PM Eastern Time.
On last trading day Workday, Inc. (NYSE:WDAY) advanced 0.72% to close at $88.53. Its volatility for the week is 2.49% while volatility for the month is 2.95%. WDAY’s sales growth for past 5 years was 63.20% and its EPS growth for past 5 years was 9.50%. Workday, Inc. (NYSE:WDAY) monthly performance is 6.33%. On Apr 21, Workday, Inc. (NYSE:WDAY), announced that Northern & Shell, a leading magazine and newspaper publisher in the United Kingdom (UK), has selected Workday Financial Management. With Workday, Northern & Shell will move its financials off a legacy system and into the cloud, providing greater financial scalability, speed, and real-time reporting and analytics to support business growth and changes in a complex and highly competitive publishing industry.
PNM Resources, Inc. (NYSE:PNM) has 0.60% insider ownership while its institutional ownership stands at 89.20%. In last trading activity company’s stock closed at $28.57. PNM Resources (NYSE:PNM) had its price objective trimmed by KeyBanc from $31.00 to $30.00 in a report released on Wednesday. KeyBanc currently has an overweight rating on the stock.
On last trading day Bovie Medical Corporation (NYSEMKT:BVX) decreased -0.31% to close at $3.19. Its volatility for the week is 11.50% while volatility for the month is 7.33%. BVX’s sales growth for past 5 years was 0.50% and its EPS growth for past 5 years was -26.87%. Bovie Medical Corporation (NYSEMKT:BVX) monthly performance is 30.20%. On April 24, Bovie Medical Corporation (NYSE:BVX), announced that it will issue its financial results for the first quarter ended March 31, 2015 on Friday May 8, before market open.